Agilent Technologies' trading volume on February 26 was $722 million, an increase of 134.54% compared to the previous trading day.

robot
Abstract generation in progress

On February 26, 2026, Agilent Technologies (A), a life sciences tools and services company, had a trading volume of $722 million, ranking 184th among U.S. stocks that day. The trading volume increased by 134.54% compared to the previous day, with a total of 6.0954 million shares traded.

On February 26, 2026, Agilent Technologies (A) fell 3.01%, closing at $120.97. The stock declined by 4.25% over the past five trading days, 9.62% for the entire month of February, 11.10% since the beginning of the year, and 10.04% over the past 52 weeks.

*If the company has been listed for less than 52 weeks, the 52-week change is calculated from the listing date to the present (this also applies to companies listed for less than 1 month or fewer than 5 trading days).

Agilent Technologies (A) Trading Volume / USD Change from Previous Day Shares Traded
February 26, 2026 $722 million +134.54% 6.0954 million
February 25, 2026 $308 million -9.54% 2.4693 million
February 24, 2026 $340 million +17.48% 2.7297 million
February 23, 2026 $290 million -44.50% 2.3595 million
February 20, 2026 $522 million +120.62% 4.243 million

Agilent Technologies released its Q1 FY2026 earnings report on February 25, 2026. Revenue for the period from November 1, 2025, to January 31, 2026, was $1.798 billion, a 6.96% increase year-over-year. Net profit was $305 million, down 4.09% year-over-year.

On February 26, 2026, Barclays maintained an “Overweight” rating on Agilent Technologies with a target price of $150.

Agilent Technologies was incorporated in Delaware in May 1999. It is a global leader in the life sciences, diagnostics, and applied markets, providing application-centric solutions across the entire laboratory workflow, including instruments, software, services, and consumables.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin